IMF TV

From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF-TV is your all-access ticket to critical myeloma research, patient education and guidance. Check back often for regularly updated content. 

Feb
20
BSRI Moves Ever Closer to a Cure
The IMF’s Black Swan Research Initiative has changed the way we look at multiple myeloma. Six years ago, the original team, led by IMF Chairman Brian G.M. Durie, MD, concluded that the only way to(...)
Feb
14
Is the combination of Velcade, Revlimid, and dexamethasone (VRd) helpful for myeloma patients over the age of 65?
In this week’s video, Dr. Brian G.M. Durie discusses various trials that were presented at ASH and the triple therapy options that are available for myeloma patients of all ages.
Feb
06
What is a BiTE and how likely is it to help me to achieve a response and remission for my myeloma?
In this week’s video, Dr. Brian G.M. Durie discusses what BiTEs are and how they may help achieve a response in patients with myeloma. BOTTOM LINE: ​ BiTEs are new monoclonal antibody forms of(...)
Feb
06
“We Don’t Believe in Chance Here”: The iStopMM Project @ Year Two
A behind-the-scenes look at the largest, most ambitious myeloma study in the world as it completes its second year. Supported by the IMF’s Black Swan Research Initiative, the Iceland-based iStopMM(...)
Jan
31
How do you tell if you’re in remission?
In this week’s video, Dr. Brian G.M. Durie explains what remission is and how to tell whether or not you are in remission as a myeloma patient
Jan
24
Why do some doctors decide to add new treatment when myeloma protein levels increase, whereas other doctors decide to watch and wait?
In this week’s video, Dr. Brian G.M. Durie discusses whether it is best to watch and wait or to shift treatment when myeloma protein levels increase. BOTTOM LINE: ​ Early treatment or “watching and(...)